OM
BIND

Opaleye Management’s BIND THERAPEUTICS INC BIND Stock Holding History

Opaleye Management’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-450,000
Closed -$3.87M – 43
2014
Q3 		$3.87M Sell
450,000
-42,000
-9% -$414K 3.01% 13
2014
Q2 		$6.49M Buy
492,000
+65,000
+15% +$636K 5.59% 6
2014
Q1 		$5.11M Buy
427,000
+272,000
+175% +$3.55M 3.77% 8
2013
Q4 		$2.12M Buy
+155,000
New +$1.97M 1.67% 17

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Opaleye Management's BIND Position: Q4 2014 in Review

Opaleye Management sold out of BIND THERAPEUTICS INC (BIND) in Q4 2014, closing a stake of 450,000 shares — an estimated $3.87M sold.

Opaleye Management first reported a position in BIND in Q4 2013 and held it in 4 quarters. The position peaked at $6.49M in Q2 2014. 37 funds tracked by Wall St. Rank hold BIND as of Q4 2014.

  • Opaleye Management reported no remaining BIND THERAPEUTICS INC position as of Q4 2014 after selling out during the quarter.
  • Opaleye Management sold 450,000 BIND THERAPEUTICS INC shares in Q4 2014, an estimated $3.87M.
  • Opaleye Management first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 4 quarters.
  • Opaleye Management's BIND THERAPEUTICS INC position peaked at $6.49M in Q2 2014.
  • 37 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q4 2014.

Based on Opaleye Management's 13F filing for Q4 2014, filed 13 Feb 2015.